Publications by authors named "Matthias Scheiner"

Claim this Profile
T
Total Syntheses of the Amaryllidaceae Alkaloids Carltonines A-C and the Neuroprotective and Immunomodulatory Evaluation of Carltonine B.
Kora Reichau, Matthias Scheiner, Eleonora Poeta, Gerhard Bringmann, Barbara Monti

J Nat Prod· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.
Allison Carles, Matthias Hoffmann, Matthias Scheiner, Lucie Crouzier, Christelle Bertrand-Gaday

CNS Neurosci Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon Irradiation.
Matthias Scheiner, Alexandra Sink, Matthias Hoffmann, Cassandre Vrigneau, Erik Endres

J Am Chem Soc· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
Caterina Pont, Tiziana Ginex, Christian Griñán-Ferré, Matthias Scheiner, Alexia Mattellone

Eur J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Structure of Cyclodecatriene Collinolactone, its Biosynthesis, and Semisynthetic Analogues: Effects of Monoastral Phenotype and Protection from Intracellular Oxidative Stress.
Julian C Schmid, Kerstin Frey, Matthias Scheiner, Jaime Felipe Guerrero Garzón, Luise Stafforst

Angew Chem Int Ed Engl· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model.
Matthias Scheiner, Matthias Hoffmann, Feng He, Eleonora Poeta, Arnaud Chatonnet

J Med Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation.
Julian Hofmann, Tiziana Ginex, Alba Espargaró, Matthias Scheiner, Sandra Gunesch

Chemistry· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model.
Feng He, C James Chou, Matthias Scheiner, Eleonora Poeta, Natalia Yuan Chen

J Med Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sterubin: Enantioresolution and Configurational Stability, Enantiomeric Purity in Nature, and Neuroprotective Activity in Vitro and in Vivo.
Julian Hofmann, Shaimaa Fayez, Matthias Scheiner, Matthias Hoffmann, Sabrina Oerter

Chemistry· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands.
Diego Alejandro Rodríguez-Soacha, Matthias Scheiner, Michael Decker

Eur J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model.
Matthias Hoffmann, Carina Stiller, Erik Endres, Matthias Scheiner, Sandra Gunesch

J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.
Matthias Scheiner, Dominik Dolles, Sandra Gunesch, Matthias Hoffmann, Massimo Nabissi

J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2 R Ligands To Combat Neurodegenerative Disorders.
Dominik Dolles, Martin Nimczick, Matthias Scheiner, Jacqueline Ramler, Patricia Stadtmüller

ChemMedChem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis